Literature DB >> 29883247

Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant Escherichia coli Isolates from Yemen.

Sameer Ahmed Alsharapy1,2, Betitera Yanat3, Lorena Lopez-Cerero4,5,6, Samar Saeed Nasher2, Paula Díaz-De-Alba4, Álvaro Pascual4,5,6,7, José-Manuel Rodríguez-Martínez5,6,7, Abdelaziz Touati1.   

Abstract

Objective: The aim of this study was to characterize the O25b/ST131 clone in ciprofloxacin-resistant Escherichia coli isolates from Yemen. Materials and
Methods: A total of 41 ciprofloxacin-resistant E. coli strains were collected from clinical samples of inpatients and outpatients from Sana'a (Yemen) from January to December 2013. Antimicrobial susceptibility testing, polymerase chain reaction amplification, and sequencing were used for detection of plasmid-mediated quinolone resistance determinants, extended-spectrum beta-lactamases genes and mutations in the quinolone resistance-determining regions of the target genes gyrA and parC. Genetic relatedness of E. coli isolates was determined by pulsed-field gel electrophoresis (PFGE). O25b/ST131 clone detection was performed using polymerase chain reaction of O25b rfb and allele 3 of the pabB gene and by a multilocus sequence typing.
Results: All E. coli isolates contained the aac(6')Ib-cr gene associated with blaCTX-M-15 and qnrS genes in 63.4% and 12.2%, respectively. A rate of 36.6% (15/41) of O25b/ST131 E. coli isolates were identified belonging to the H30-Rx subclone producing both CTX-M-15 and Aac(6')Ib-cr enzymes and carrying two substitutions in GyrA (Ser83Leu/Asp87Asn) and two substitutions in ParC (Ser80Ile/Glu84Val). Most of them were uropathogenic unrelated E. coli isolates recovered from outpatients.
Conclusion: This is the first report of a high prevalence of E. coli O25b/ST131 from Yemen.

Entities:  

Keywords:  Aac(6′)Ib-cr; CTX-M-15; E. coli,; O25b-ST131; Yemen

Mesh:

Substances:

Year:  2018        PMID: 29883247     DOI: 10.1089/mdr.2018.0024

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.

Authors:  Minh-Duy Phan; Kate M Peters; Laura Alvarez Fraga; Steven C Wallis; Steven J Hancock; Nguyen Thi Khanh Nhu; Brian M Forde; Michelle J Bauer; David L Paterson; Scott A Beatson; Jeffrey Lipman; Mark A Schembri
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

2.  Antibiotic Resistance and Virulence of Extraintestinal Pathogenic Escherichia coli (ExPEC) Vary According to Molecular Types.

Authors:  Yitao Duan; Huihui Gao; Liyang Zheng; Shuangqing Liu; Yang Cao; Siyuan Zhu; Zhenzhe Wu; Hongqiang Ren; Daqing Mao; Yi Luo
Journal:  Front Microbiol       Date:  2020-11-25       Impact factor: 5.640

3.  Genomic comparisons of Escherichia coli ST131 from Australia.

Authors:  Dmitriy Li; Ethan R Wyrsch; Paarthiphan Elankumaran; Monika Dolejska; Marc S Marenda; Glenn F Browning; Rhys N Bushell; Jessica McKinnon; Piklu Roy Chowdhury; Nola Hitchick; Natalie Miller; Erica Donner; Barbara Drigo; Dave Baker; Ian G Charles; Timothy Kudinha; Veronica M Jarocki; Steven Philip Djordjevic
Journal:  Microb Genom       Date:  2021-12

4.  Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú

Authors:  Jose Matta-Chuquisapon; Esther Valencia-Bazalar; Carlos Sevilla-Andrade; Helí Jaime Barrón-Pastor
Journal:  Biomedica       Date:  2022-09-02       Impact factor: 1.173

Review 5.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.